Stock 688488 JIANGSU AIDEA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangsu Aidea Pharmaceutical Co., Ltd.

Equities

688488

CNE1000041S6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 30/06/2024 BST 		5-day change 1st Jan Change
9.89 CNY -3.23% Intraday chart for Jiangsu Aidea Pharmaceutical Co., Ltd. -23.33% -20.94%
05-14 Jiangsu Aidea Pharmaceutical Co., Ltd. entered into an agreement to acquire 31.161% stake in Nanjing Nanda Pharmaceutical Co., Ltd. CI
04-25 Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Jiangsu Aidea Pharmaceutical Co Ltd is a China-based company mainly engaged in the production and sales of human-source protein products. The Company is also engaged in the development and sales of some generic drugs, human immunodeficiency virus (HIV) diagnostic equipment and reagents. The Company is also engaged in the research and development of innovative drugs in anti-Acquired Immune Deficiency Syndrome (AIDS), anti-inflammatory and anti-tumor drugs fields. The Company's human-source protein products mainly include crude ulinastatin, crude urekline, crude urokinase and intermediates of ulinastatin. The Company mainly distributes its products within domestic market.

Number of employees: 476

Sales per Business

CNY in Million2022Weight2023Weight Delta
Crude Urokinase
43.0 %
103 42.3 % 177 43.0 % +71.46%
Ulinastatin Crude
19.3 %
40 16.4 % 80 19.3 % +98.15%
Senna Granules
15.6 %
50 20.3 % 64 15.6 % +29.63%
New HIV Drug (Enomitide Tablets)
11.9 %
- - 49 11.9 % -
New HIV Drug (EnovirineTablets)
6.0 %
33 13.7 % 25 6.0 % -26.15%
HIV Diagnostic Reagents
1.8 %
12 5.0 % 7 1.8 % -40.95%
Bacillus Cereus Tablets
1.0 %
3 1.4 % 4 1.0 % +19.19%
Other Crude Human Protein
0.8 %
0 0.0 % 3 0.8 % +6,509.67%
Other Business
0.6 %
1 0.6 % 2 0.6 % +69.38%
Other Generic Drugs
0.0 %
0 0.0 % 0 0.0 % -997.00%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
244 100.0 % 411 100.0 % +68.44%

Managers

Managers TitleAgeSince
Jie Zhang CEO
 Chief Executive Officer 54 -
Chuanhong Zhu DFI
 Director of Finance/CFO 53 15/09/23
He Liang Fu CHM
 Chairman 63 31/12/13
Qi Hong CTO
 Chief Tech/Sci/R&D Officer 61 18/01/21
Jun Wang COO
 Chief Operating Officer 50 31/12/13
Guang Rong Wang BRD
 Director/Board Member 48 31/12/14
Wei Xuan Zhou IRC
 Investor Relations Contact 34 31/07/20
Yan Liu SEC
 Corporate Secretary 42 13/03/23

Members of the board

Members of the board TitleAgeSince
He Liang Fu CHM
 Chairman 63 31/12/13
Guang Ji Wang BRD
 Director/Board Member 71 08/05/19
Xiao Yan Qi BRD
 Director/Board Member 61 09/03/22
Guang Rong Wang BRD
 Director/Board Member 48 31/12/14
Jun Wang COO
 Chief Operating Officer 50 31/12/13
Heng Yu CHM
 Chairman 44 30/11/09
Feng Ying He BRD
 Director/Board Member 41 30/11/14
Zijian Guo BRD
 Director/Board Member 63 14/09/23
Jie Zhang CEO
 Chief Executive Officer 54 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 420,782,808 185,754,481 ( 44.14 %) 0 44.14 %

Shareholders

NameEquities%Valuation
Zhong Geng Fund Management Co. , Ltd.
15.03 %
32,424,493 15.03 % 68 M ¥
Bank of China Investment Management Co., Ltd.
4.442 %
9,582,890 4.442 % 20 M ¥
Huisheng Fund Management Co., Ltd.
0.5830 %
1,257,833 0.5830 % 3 M ¥
Guotai Asset Management Co., Ltd.
0.3351 %
722,963 0.3351 % 2 M ¥
China Southern Asset Management Co., Ltd.
0.3108 %
670,489 0.3108 % 1 M ¥
AXA-SPDB Investment Managers Co., Ltd.
0.2479 %
534,799 0.2479 % 1 M ¥
ABC-CA Fund Management Co., Ltd.
0.2088 %
450,567 0.2088 % 939 820 ¥
Caitong Securities Asset Management Co., Ltd.
0.1863 %
401,995 0.1863 % 838 505 ¥
Penghua Fund Management Co., Ltd.
0.1721 %
371,356 0.1721 % 774 597 ¥
China Asset Management Co., Ltd.
0.1320 %
284,851 0.1320 % 594 159 ¥

Company contact information

Jiangsu Aidea Pharmaceutical Co., Ltd.

No.69 New Ganquan West Road Hanjiang District

225008, Yangzhou

+

http://www.aidea.com.cn
address Jiangsu Aidea Pharmaceutical Co., Ltd.(688488)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
9.89 CNY
Average target price
20.82 CNY
Spread / Average Target
+110.52%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
JIANGSU AIDEA PHARMACEUTICAL CO., LTD. Stock Jiangsu Aidea Pharmaceutical Co., Ltd.
-20.94% 592M
CSL LIMITED Stock CSL Limited
+2.08% 95.18B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
-0.13% 37.55B
BIOGEN INC. Stock Biogen Inc.
-10.26% 33.75B
UCB Stock UCB
+77.76% 28.2B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-14.46% 15.63B
INCYTE CORPORATION Stock Incyte Corporation
-2.83% 13.63B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.76% 11.5B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+181.73% 10.81B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-53.92% 9.23B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 688488 Stock
  4. Company Jiangsu Aidea Pharmaceutical Co., Ltd.